CELG.RT
Bank of America’s Bristol-Myers Squibb Company Contingent Value Rights CELG.RT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3K | Buy |
51,828
+10
| +0% | – | ﹤0.01% | 6447 |
|
|
2025
Q1 | $2.59K | Buy |
51,818
+180
| +0.3% | +$9 | ﹤0.01% | 6253 |
|
|
2024
Q4 | $2.53K | Hold |
51,638
| – | – | ﹤0.01% | 6252 |
|
|
2024
Q3 | $2.48K | Buy |
51,638
+49,800
| +2,709% | +$2.39K | ﹤0.01% | 6169 |
|
|
2024
Q2 | $75 | Hold |
1,838
| – | – | ﹤0.01% | 6869 |
|
|
2024
Q1 | $101 | Buy |
1,838
+200
| +12% | +$11 | ﹤0.01% | 6491 |
|
|
2023
Q4 | $147 | Hold |
1,638
| – | – | ﹤0.01% | 6409 |
|
|
2023
Q3 | $156 | Sell |
1,638
-26
| -2% | -$2 | ﹤0.01% | 6499 |
|
|
2023
Q2 | $183 | Sell |
1,664
-5
| -0.3% | -$1 | ﹤0.01% | 6494 |
|
|
2023
Q1 | $200 | Hold |
1,669
| – | – | ﹤0.01% | 6598 |
|
|
2022
Q4 | $197 | Sell |
1,669
-5
| -0.3% | -$1 | ﹤0.01% | 6721 |
|
|
2022
Q3 | $0 | Hold |
1,674
| – | – | ﹤0.01% | 6949 |
|
|
2022
Q2 | $0 | Sell |
1,674
-30
| -2% | – | ﹤0.01% | 7166 |
|
|
2022
Q1 | $0 | Buy |
1,704
+30
| +2% | – | ﹤0.01% | 7427 |
|
|
2021
Q4 | $0 | Hold |
1,674
| – | – | ﹤0.01% | 7340 |
|
|
2021
Q3 | $0 | Hold |
1,674
| – | – | ﹤0.01% | 7181 |
|
|
2021
Q2 | $0 | Hold |
1,674
| – | – | ﹤0.01% | 6922 |
|
|
2021
Q1 | $0 | Sell |
1,674
-50
| -3% | – | ﹤0.01% | 6692 |
|
|
2020
Q4 | $1K | Hold |
1,724
| – | – | ﹤0.01% | 6204 |
|
|
2020
Q3 | $1K | Hold |
1,724
| – | – | ﹤0.01% | 6078 |
|
|
2020
Q2 | $1K | Hold |
1,724
| – | – | ﹤0.01% | 6098 |
|
|
2020
Q1 | $1K | Buy |
1,724
+180
| +12% | +$104 | ﹤0.01% | 6065 |
|
|
2019
Q4 | $1K | Buy |
+1,544
| New | +$1K | ﹤0.01% | 6103 |
|